×




Shenzhen Mindray Bio-Medical (300760) SWOT Analysis / TOWS Matrix / MBA Resources

Introduction to SWOT Analysis

SWOT Analysis / TOWS Matrix for Shenzhen Mindray Bio-Medical (China)


Based on various researches at Oak Spring University , Shenzhen Mindray Bio-Medical is operating in a macro-environment that has been destablized by – banking and financial system is disrupted by Bitcoin and other crypto currencies, there is increasing trade war between United States & China, increasing inequality as vast percentage of new income is going to the top 1%, increasing commodity prices, central banks are concerned over increasing inflation, geopolitical disruptions, digital marketing is dominated by two big players Facebook and Google, customer relationship management is fast transforming because of increasing concerns over data privacy, increasing household debt because of falling income levels, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of Shenzhen Mindray Bio-Medical


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University, we believe that Shenzhen Mindray Bio-Medical can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Shenzhen Mindray Bio-Medical, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Shenzhen Mindray Bio-Medical operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of Shenzhen Mindray Bio-Medical can be done for the following purposes –
1. Strategic planning of Shenzhen Mindray Bio-Medical
2. Improving business portfolio management of Shenzhen Mindray Bio-Medical
3. Assessing feasibility of the new initiative in China
4. Making a Medical Equipment & Supplies sector specific business decision
5. Set goals for the organization
6. Organizational restructuring of Shenzhen Mindray Bio-Medical




Strengths of Shenzhen Mindray Bio-Medical | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of Shenzhen Mindray Bio-Medical are -

Learning organization

- Shenzhen Mindray Bio-Medical is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Shenzhen Mindray Bio-Medical is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders at Shenzhen Mindray Bio-Medical emphasize – knowledge, initiative, and innovation.

Cross disciplinary teams

– Horizontal connected teams at the Shenzhen Mindray Bio-Medical are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.

High brand equity

– Shenzhen Mindray Bio-Medical has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Shenzhen Mindray Bio-Medical to keep acquiring new customers and building profitable relationship with both the new and loyal customers.

Diverse revenue streams

– Shenzhen Mindray Bio-Medical is present in almost all the verticals within the Medical Equipment & Supplies industry. This has provided Shenzhen Mindray Bio-Medical a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.

Organizational Resilience of Shenzhen Mindray Bio-Medical

– The covid-19 pandemic has put organizational resilience at the centre of everthing Shenzhen Mindray Bio-Medical does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.

Highly skilled collaborators

– Shenzhen Mindray Bio-Medical has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive Medical Equipment & Supplies industry. Secondly the value chain collaborators of Shenzhen Mindray Bio-Medical have helped the firm to develop new products and bring them quickly to the marketplace.

Ability to lead change in Medical Equipment & Supplies

– Shenzhen Mindray Bio-Medical is one of the leading players in the Medical Equipment & Supplies industry in China. Over the years it has not only transformed the business landscape in the Medical Equipment & Supplies industry in China but also across the existing markets. The ability to lead change has enabled Shenzhen Mindray Bio-Medical in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.

Successful track record of launching new products

– Shenzhen Mindray Bio-Medical has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Shenzhen Mindray Bio-Medical has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.

Strong track record of project management in the Medical Equipment & Supplies industry

– Shenzhen Mindray Bio-Medical is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

High switching costs

– The high switching costs that Shenzhen Mindray Bio-Medical has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.

Training and development

– Shenzhen Mindray Bio-Medical has one of the best training and development program in Healthcare industry. The effectiveness of the training programs can be measured in – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.

Low bargaining power of suppliers

– Suppliers of Shenzhen Mindray Bio-Medical in the Healthcare sector have low bargaining power. Shenzhen Mindray Bio-Medical has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Shenzhen Mindray Bio-Medical to manage not only supply disruptions but also source products at highly competitive prices.






Weaknesses of Shenzhen Mindray Bio-Medical | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of Shenzhen Mindray Bio-Medical are -

Workers concerns about automation

– As automation is fast increasing in the Medical Equipment & Supplies industry, Shenzhen Mindray Bio-Medical needs to come up with a strategy to reduce the workers concern regarding automation. Without a clear strategy, it could lead to disruption and uncertainty within the organization.

Slow to harness new channels of communication

– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, Shenzhen Mindray Bio-Medical is slow explore the new channels of communication. These new channels of communication can help Shenzhen Mindray Bio-Medical to provide better information regarding Medical Equipment & Supplies products and services. It can also build an online community to further reach out to potential customers.

Capital Spending Reduction

– Even during the low interest decade, Shenzhen Mindray Bio-Medical has not been able to do capital spending to the tune of the competition. This has resulted into fewer innovations and company facing stiff competition from both existing competitors and new entrants who are disrupting the Medical Equipment & Supplies industry using digital technology.

Employees’ less understanding of Shenzhen Mindray Bio-Medical strategy

– From the outside it seems that the employees of Shenzhen Mindray Bio-Medical don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.

High bargaining power of channel partners in Medical Equipment & Supplies industry

– because of the regulatory requirements in China, Shenzhen Mindray Bio-Medical is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the Medical Equipment & Supplies industry.

Compensation and incentives

– The revenue per employee of Shenzhen Mindray Bio-Medical is just above the Medical Equipment & Supplies industry average. It needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.

Low market penetration in new markets

– Outside its home market of China, Shenzhen Mindray Bio-Medical needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.

Need for greater diversity

– Shenzhen Mindray Bio-Medical has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.

High cash cycle compare to competitors

Shenzhen Mindray Bio-Medical has a high cash cycle compare to other players in the Medical Equipment & Supplies industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.

Increasing silos among functional specialists

– The organizational structure of Shenzhen Mindray Bio-Medical is dominated by functional specialists. It is not different from other players in the Medical Equipment & Supplies industry, but Shenzhen Mindray Bio-Medical needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help Shenzhen Mindray Bio-Medical to focus more on services in the Medical Equipment & Supplies industry rather than just following the product oriented approach.

Products dominated business model

– Even though Shenzhen Mindray Bio-Medical has some of the most successful models in the Medical Equipment & Supplies industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. Shenzhen Mindray Bio-Medical should strive to include more intangible value offerings along with its core products and services.




Shenzhen Mindray Bio-Medical Opportunities | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities of Shenzhen Mindray Bio-Medical are -

Use of Bitcoin and other crypto currencies for transactions in Medical Equipment & Supplies industry

– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Shenzhen Mindray Bio-Medical in the Medical Equipment & Supplies industry. Now Shenzhen Mindray Bio-Medical can target international markets with far fewer capital restrictions requirements than the existing system.

Developing new processes and practices

– Shenzhen Mindray Bio-Medical can develop new processes and procedures in Medical Equipment & Supplies industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.

Finding new ways to collaborate

– Covid-19 has not only transformed business models of companies in Medical Equipment & Supplies industry, but it has also influenced the consumer preferences. Shenzhen Mindray Bio-Medical can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.

Loyalty marketing

– Shenzhen Mindray Bio-Medical has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Leveraging digital technologies

– Shenzhen Mindray Bio-Medical can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Lowering marketing communication costs

– 5G expansion will open new opportunities for Shenzhen Mindray Bio-Medical in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Medical Equipment & Supplies industry, and it will provide faster access to the consumers.

Manufacturing automation

– Shenzhen Mindray Bio-Medical can use the latest technology developments to improve its manufacturing and designing process in Medical Equipment & Supplies sector. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Low interest rates

– Even though inflation is raising its head in most developed economies, Shenzhen Mindray Bio-Medical can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects Shenzhen Mindray Bio-Medical can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Increase in government spending

– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Shenzhen Mindray Bio-Medical can use these opportunities to build new business models that can help the communities that Shenzhen Mindray Bio-Medical operates in. Secondly it can use opportunities from government spending in Medical Equipment & Supplies sector.

Better consumer reach

– The expansion of the 5G network will help Shenzhen Mindray Bio-Medical to increase its market reach. Shenzhen Mindray Bio-Medical will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.

Using analytics as competitive advantage

– Shenzhen Mindray Bio-Medical has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in Medical Equipment & Supplies sector. This continuous investment in analytics has enabled Shenzhen Mindray Bio-Medical to build a competitive advantage using analytics. The analytics driven competitive advantage can help Shenzhen Mindray Bio-Medical to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.

Buying journey improvements

– Shenzhen Mindray Bio-Medical can improve the customer journey of consumers in the Medical Equipment & Supplies industry by using analytics and artificial intelligence. It can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.




Threats Shenzhen Mindray Bio-Medical External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats of Shenzhen Mindray Bio-Medical are -

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Consumer confidence and its impact on Shenzhen Mindray Bio-Medical demand

– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in Medical Equipment & Supplies industry and other sectors.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry to Medical Equipment & Supplies industry are lowering. It can presents Shenzhen Mindray Bio-Medical with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the Medical Equipment & Supplies sector.

Environmental challenges

– Shenzhen Mindray Bio-Medical needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Shenzhen Mindray Bio-Medical can take advantage of this fund but it will also bring new competitors in the Medical Equipment & Supplies industry.

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Shenzhen Mindray Bio-Medical will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Shenzhen Mindray Bio-Medical needs to understand the core reasons impacting the Medical Equipment & Supplies industry. This will help it in building a better workplace.

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Shenzhen Mindray Bio-Medical.

Stagnating economy with rate increase

– Shenzhen Mindray Bio-Medical can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the Medical Equipment & Supplies industry.

Easy access to finance

– Easy access to finance in Medical Equipment & Supplies industry will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Shenzhen Mindray Bio-Medical can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.

Increasing wage structure of Shenzhen Mindray Bio-Medical

– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Shenzhen Mindray Bio-Medical.

Increasing international competition and downward pressure on margins

– Apart from technology driven competitive advantage dilution, Shenzhen Mindray Bio-Medical can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate Shenzhen Mindray Bio-Medical prominent markets.

Trade war between China and United States

– The trade war between two of the biggest economies can hugely impact the opportunities for Shenzhen Mindray Bio-Medical in Medical Equipment & Supplies industry. The Medical Equipment & Supplies industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.

Backlash against dominant players

– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Shenzhen Mindray Bio-Medical business can come under increasing regulations regarding data privacy, data security, etc.




Weighted SWOT Analysis of Shenzhen Mindray Bio-Medical Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers at Shenzhen Mindray Bio-Medical needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of Shenzhen Mindray Bio-Medical is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of Shenzhen Mindray Bio-Medical is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of Shenzhen Mindray Bio-Medical to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Shenzhen Mindray Bio-Medical needs to make to build a sustainable competitive advantage.



--- ---

Hakudo Co Ltd SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Apex Frozen Foods SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Fish/Livestock


ABB SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


Arcs Co Ltd SWOT Analysis / TOWS Matrix

Services , Retail (Grocery)


Broccoli SWOT Analysis / TOWS Matrix

Services , Motion Pictures


Western Asset Income Fund SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Bunge SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing